US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist
  • 0.3373
  • +0.0323+10.59%
Close Nov 29 13:00 ET
  • 0.3200
  • -0.0173-5.13%
Post 17:01 ET
1.50MMarket Cap-61P/E (TTM)

TFF Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.03%-1.98M
27.02%-3.25M
27.98%-3.14M
41.34%-16.04M
45.29%-4.21M
59.34%-3M
11.09%-4.46M
39.75%-4.37M
7.49%-27.34M
29.23%-7.7M
Net income from continuing operations
19.60%-3.54M
10.78%-4.48M
18.67%-5.74M
33.13%-21.24M
35.41%-4.76M
39.39%-4.41M
42.60%-5.02M
15.81%-7.05M
-2.36%-31.77M
26.63%-7.37M
Depreciation and amortization
12.71%141.02K
13.81%140.59K
13.82%140.18K
29.43%502.48K
8.07%130.67K
23.71%125.12K
38.57%123.53K
59.90%123.17K
248.33%388.22K
56.97%120.91K
Other non cash items
--0
5,682.84%560.47K
-1.88%-27.22K
---497.03K
---529K
--49K
--9.69K
---26.72K
----
----
Change In working capital
83.00%856.67K
78.92%-83.68K
69.81%1.85M
819.27%1.53M
126.56%364.71K
140.30%468.13K
-116.21%-396.86K
971.76%1.09M
90.26%-212.15K
25.02%-1.37M
-Change in receivables
212.81%100.99K
-6.33%-103.53K
615.71%128.44K
-145.81%-259.8K
-105.62%-48.01K
-257.35%-89.52K
-1,386.00%-97.36K
90.27%-24.91K
121.59%567.13K
236.34%854.71K
-Change in prepaid assets
-20.78%513.81K
249.59%288.12K
-56.47%298.31K
715.36%1.48M
105.14%64.43K
31.29%648.56K
-88.27%82.42K
188.38%685.33K
189.30%181.6K
22.27%-1.25M
-Change in payables and accrued expense
275.51%37.91K
60.91%-132.24K
232.75%1.41M
140.97%405.48K
130.13%343K
98.74%-21.6K
-120.32%-338.25K
119.72%422.33K
-573.05%-989.59K
-1,789.51%-1.14M
-Change in other current liabilities
-12.48%-21.72K
-12.65%-21.03K
-13.02%-20.1K
-59.54%-75.47K
-13.01%-19.7K
-13.02%-19.31K
-46.05%-18.67K
---17.78K
---47.3K
---17.43K
-Change in other working capital
--225.7K
---115K
56.00%39K
-132.89%-25K
-86.13%25K
----
----
108.36%25K
-82.83%76K
-61.41%180.2K
Cash from discontinued investing activities
Operating cash flow
34.03%-1.98M
27.02%-3.25M
27.98%-3.14M
41.34%-16.04M
45.29%-4.21M
59.34%-3M
11.09%-4.46M
39.75%-4.37M
7.49%-27.34M
29.23%-7.7M
Investing cash flow
Cash flow from continuing investing activities
0
93.89%-94.75K
67.14%-46.39K
98.37%-12.65K
-78.62%-1.55M
-11.46%-141.17K
Net PPE purchase and sale
--0
----
----
93.89%-94.75K
67.14%-46.39K
98.37%-12.65K
----
----
-78.62%-1.55M
-11.46%-141.17K
Cash from discontinued investing activities
Investing cash flow
--0
----
----
93.89%-94.75K
67.14%-46.39K
98.37%-12.65K
----
----
-78.62%-1.55M
-11.46%-141.17K
Financing cash flow
Cash flow from continuing financing activities
-96.09%199.07K
7,570.56%4.42M
5,128.68%901.14K
-57.34%5.01M
-99.99%567
1,081.70%5.09M
-270.30%-59.23K
-17.92K
-59.32%11.75M
11.34M
Net common stock issuance
-95.66%220.8K
--5.4M
--12.58K
-56.00%5.12M
-99.71%32.12K
--5.09M
--0
--0
-58.45%11.64M
--11.24M
Proceeds from stock option exercised by employees
----
----
--903.56K
--0
----
----
----
--0
-87.26%110.82K
--100.64K
Net other financing activities
---21.74K
-14.35%-67.73K
16.29%-15K
---108.7K
---31.55K
--0
---59.23K
---17.92K
----
----
Cash from discontinued financing activities
Financing cash flow
-96.09%199.07K
7,570.56%4.42M
5,128.68%901.14K
-57.34%5.01M
-99.99%567
1,081.70%5.09M
-270.30%-59.23K
---17.92K
-59.32%11.75M
--11.34M
Net cash flow
Beginning cash position
-42.75%4.39M
-73.71%3.21M
-67.02%5.48M
-50.84%16.61M
-26.02%9.73M
-63.32%7.66M
-53.75%12.22M
-50.84%16.61M
-4.27%33.79M
-70.60%13.15M
Current changes in cash
-185.74%-1.78M
125.72%1.17M
48.83%-2.24M
35.13%-11.12M
-221.94%-4.26M
126.88%2.08M
17.60%-4.55M
40.63%-4.38M
-1,012.79%-17.14M
131.73%3.49M
Effect of exchange rate changes
98.61%-193
1,345.96%4.01K
-88.17%-23.06K
63.21%-14.67K
142.24%11.79K
18.20%-13.88K
-116.30%-322
-504.26%-12.25K
-216.05%-39.87K
-131.38%-27.91K
End cash Position
-73.20%2.61M
-42.75%4.39M
-73.71%3.21M
-67.02%5.48M
-67.02%5.48M
-26.02%9.73M
-63.32%7.66M
-53.75%12.22M
-50.84%16.61M
-50.84%16.61M
Free cash flow
34.31%-1.98M
27.60%-3.25M
27.98%-3.14M
44.16%-16.13M
45.68%-4.26M
63.06%-3.01M
18.44%-4.49M
40.87%-4.37M
5.04%-28.89M
28.76%-7.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.03%-1.98M27.02%-3.25M27.98%-3.14M41.34%-16.04M45.29%-4.21M59.34%-3M11.09%-4.46M39.75%-4.37M7.49%-27.34M29.23%-7.7M
Net income from continuing operations 19.60%-3.54M10.78%-4.48M18.67%-5.74M33.13%-21.24M35.41%-4.76M39.39%-4.41M42.60%-5.02M15.81%-7.05M-2.36%-31.77M26.63%-7.37M
Depreciation and amortization 12.71%141.02K13.81%140.59K13.82%140.18K29.43%502.48K8.07%130.67K23.71%125.12K38.57%123.53K59.90%123.17K248.33%388.22K56.97%120.91K
Other non cash items --05,682.84%560.47K-1.88%-27.22K---497.03K---529K--49K--9.69K---26.72K--------
Change In working capital 83.00%856.67K78.92%-83.68K69.81%1.85M819.27%1.53M126.56%364.71K140.30%468.13K-116.21%-396.86K971.76%1.09M90.26%-212.15K25.02%-1.37M
-Change in receivables 212.81%100.99K-6.33%-103.53K615.71%128.44K-145.81%-259.8K-105.62%-48.01K-257.35%-89.52K-1,386.00%-97.36K90.27%-24.91K121.59%567.13K236.34%854.71K
-Change in prepaid assets -20.78%513.81K249.59%288.12K-56.47%298.31K715.36%1.48M105.14%64.43K31.29%648.56K-88.27%82.42K188.38%685.33K189.30%181.6K22.27%-1.25M
-Change in payables and accrued expense 275.51%37.91K60.91%-132.24K232.75%1.41M140.97%405.48K130.13%343K98.74%-21.6K-120.32%-338.25K119.72%422.33K-573.05%-989.59K-1,789.51%-1.14M
-Change in other current liabilities -12.48%-21.72K-12.65%-21.03K-13.02%-20.1K-59.54%-75.47K-13.01%-19.7K-13.02%-19.31K-46.05%-18.67K---17.78K---47.3K---17.43K
-Change in other working capital --225.7K---115K56.00%39K-132.89%-25K-86.13%25K--------108.36%25K-82.83%76K-61.41%180.2K
Cash from discontinued investing activities
Operating cash flow 34.03%-1.98M27.02%-3.25M27.98%-3.14M41.34%-16.04M45.29%-4.21M59.34%-3M11.09%-4.46M39.75%-4.37M7.49%-27.34M29.23%-7.7M
Investing cash flow
Cash flow from continuing investing activities 093.89%-94.75K67.14%-46.39K98.37%-12.65K-78.62%-1.55M-11.46%-141.17K
Net PPE purchase and sale --0--------93.89%-94.75K67.14%-46.39K98.37%-12.65K---------78.62%-1.55M-11.46%-141.17K
Cash from discontinued investing activities
Investing cash flow --0--------93.89%-94.75K67.14%-46.39K98.37%-12.65K---------78.62%-1.55M-11.46%-141.17K
Financing cash flow
Cash flow from continuing financing activities -96.09%199.07K7,570.56%4.42M5,128.68%901.14K-57.34%5.01M-99.99%5671,081.70%5.09M-270.30%-59.23K-17.92K-59.32%11.75M11.34M
Net common stock issuance -95.66%220.8K--5.4M--12.58K-56.00%5.12M-99.71%32.12K--5.09M--0--0-58.45%11.64M--11.24M
Proceeds from stock option exercised by employees ----------903.56K--0--------------0-87.26%110.82K--100.64K
Net other financing activities ---21.74K-14.35%-67.73K16.29%-15K---108.7K---31.55K--0---59.23K---17.92K--------
Cash from discontinued financing activities
Financing cash flow -96.09%199.07K7,570.56%4.42M5,128.68%901.14K-57.34%5.01M-99.99%5671,081.70%5.09M-270.30%-59.23K---17.92K-59.32%11.75M--11.34M
Net cash flow
Beginning cash position -42.75%4.39M-73.71%3.21M-67.02%5.48M-50.84%16.61M-26.02%9.73M-63.32%7.66M-53.75%12.22M-50.84%16.61M-4.27%33.79M-70.60%13.15M
Current changes in cash -185.74%-1.78M125.72%1.17M48.83%-2.24M35.13%-11.12M-221.94%-4.26M126.88%2.08M17.60%-4.55M40.63%-4.38M-1,012.79%-17.14M131.73%3.49M
Effect of exchange rate changes 98.61%-1931,345.96%4.01K-88.17%-23.06K63.21%-14.67K142.24%11.79K18.20%-13.88K-116.30%-322-504.26%-12.25K-216.05%-39.87K-131.38%-27.91K
End cash Position -73.20%2.61M-42.75%4.39M-73.71%3.21M-67.02%5.48M-67.02%5.48M-26.02%9.73M-63.32%7.66M-53.75%12.22M-50.84%16.61M-50.84%16.61M
Free cash flow 34.31%-1.98M27.60%-3.25M27.98%-3.14M44.16%-16.13M45.68%-4.26M63.06%-3.01M18.44%-4.49M40.87%-4.37M5.04%-28.89M28.76%-7.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.28%